Crinetics Pharmaceuticals (CRNX) Operating Margin (2017 - 2025)
Historic Operating Margin for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to 99710.49%.
- Crinetics Pharmaceuticals' Operating Margin changed N/A to 99710.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 31130.16%, marking a year-over-year decrease of 16049500.0%. This contributed to the annual value of 32613.47% for FY2024, which is 270663000.0% down from last year.
- According to the latest figures from Q3 2025, Crinetics Pharmaceuticals' Operating Margin is 99710.49%.
- Crinetics Pharmaceuticals' 5-year Operating Margin high stood at 1080.39% for Q1 2022, and its period low was 99710.49% during Q3 2025.
- Its 5-year average for Operating Margin is 17652.03%, with a median of 9805.24% in 2022.
- Within the past 5 years, the most significant YoY rise in Crinetics Pharmaceuticals' Operating Margin was 82246300bps (2025), while the steepest drop was -193712000bps (2025).
- Over the past 5 years, Crinetics Pharmaceuticals' Operating Margin (Quarter) stood at 2865.31% in 2021, then plummeted by -134bps to 6707.48% in 2022, then tumbled by -154bps to 17045.38% in 2023, then fell by -22bps to 20747.62% in 2024, then crashed by -381bps to 99710.49% in 2025.
- Its last three reported values are 99710.49% in Q3 2025, 12522.99% for Q2 2025, and 30860.11% during Q1 2025.